/DaVita%20Inc%20location-%20by%20sanfel%20via%20iStock.jpg)
Denver, Colorado-based DaVita Inc. (DVA) provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. Valued at a market cap of almost $12.5 billion, the company also offers outpatient, hospital inpatient, and home-based hemodialysis services and operates clinical laboratories as well.
Companies worth $10 billion or more are generally described as “large-cap” stocks, and DaVita fits right into that category. The company is a leading provider of dialysis services and is renowned for treating patients with chronic kidney failure and end-stage renal disease (ESRD). It is also known for offering a variety of healthcare services, including integrated treatment plans, personalized care teams, and health management services.